The mistake, the NYT writes, does not affect Johnson & Johnson doses currently supplied and used nationwide, which were manufactured in the Netherlands, but on future shipments of the vaccine that should have come from the massive Baltimore plant. Federal officials still expect to have enough doses to meet President Biden’s pledge to provide enough vaccines by the end of May to immunize the entire adult population.
Perspective that at the moment collides with the number of doses delivered. J&J had a goal of shipping 20 million doses to the US government by the end of March, the company claimed in a statement, but it only delivered 6.8 million and administered 3.3 million.
On the competitor front, Pfizer / BioNTech and Moderna, Pfizer delivered 98 million doses, Moderna 90 million, but this week the company said it had shipped its 100 millionth dose to the government.